It’s AnCan’s Annual Fundraiser time – just once a year is the only time we ask for donations. If you watch these videos and find them helpful, please step up ad donate – https://ancan.org/donate/
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Foundation Medicine, Janssen, Myriad Genetics, Novartis, Telix & Blue Earth Diagnostics.
WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.
All AnCan’s groups are free and drop-in … join us in person sometime!
Editor’s Pick: It is unwise to minimize needed prostate cancer treatment because earlier treatment generally leads to better outcomes. (bj)
Topics Discussed Refuse a blind biopsy, timing of radiation therapy and ADT, rationality for Decipher Pro genomic test, PROMISE germline study, running out of biopsy samples, radiation oncologist vs genitourinary oncologist, evaluating different treatment options, treat prostate or whole pelvis, diet and nutrition during and after treatment, favorable vs unfavorable intermediate risk prostate cancer, active surveillance, brachytherapy, TULSA-PRO, SBRT, IMRT, Decipher Grid, focal treatment, is PSA still the gospel, decision anxiety, Cribriform discussion, RTIRE study, Men Speaking Freely.
Chat Log
AnCan – rick
The PROMISE germline study https://www.prostatecancerpromise.org/?utm_campaign=ANCAN&utm_medium=link&utm_source=Webinar
John A
Survey deadline is this Thursday everyone.
AnCan – rick
This link is now pinned to the top, so reposting – tx Eric. https://docs.google.com/forms/d/e/1FAIpQLSfw2B3rZTMWIPqTmzLYBl1CdN9qRJSpt0f72CoK6J00zllzWw/viewform
AnCan – rick
You can donate to AnCan here: https://ancan.org/donate/
AnCan – rick
David and Michael… do we have your email addresses for Reminders.
AnCan – rick
Watch out for the Recording of tonight’s session. You can sign up for a reminder when published via our blog https://ancan.org/blog/ or our YouTube Channel https://www.youtube.com/channel/UCOX221U27DhVDCe3Ozz2rDg
AnCan – rick
Next AS Group – Feb 5, 8.00 pm Eastern in this same room. Weekly for the first 4 Wednesdays.
AnCan – rick
Decipher GRID
AnCan – rick
You’re not alone, Mark!!
AnCan – rick
Cribriform discussion – 30 min webinar https://www.urotoday.com/video-lectures/a-journal-club-for-patients-with-prostate-cancer/video/mediaitem/4452-unfavorable-histology-classification-aims-to-reduce-unnecessary-treatment-journal-club-jesse-mckenney-cornelia-ding.html
AnCan – rick
Epstein’s new email for reread: gdeliguori@imppllc.com
Stuart
Ming Zhou – Ming.zhou@mountsinai.org
AnCan – rick
Men Speaking Freely https://ancan.org/speaking-freely/
Mark Perloe
Thanks Richard
Sandy
Thanks all. very helpful again tonight. Signing off
Joe M, Victoria BC
Gotta sign off — thanks all for a good meeting.
It’s AnCan’s Annual Fundraiser time – just once a year is the only time we ask for donations. If you watch these videos and find them helpful, please step up ad donate – https://ancan.org/donate/
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Foundation Medicine, Janssen, Myriad Genetics, Novartis, Telix & Blue Earth Diagnostics.
WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.
All AnCan’s groups are free and drop-in … join us in person sometime!
Editor’s Pick: A transperineal biopsy with sedation may be a safer alternative to a transrectal biopsy. (bj)
Topics Discussed
Frequent urination, low testosterone, CAT scan, Transrectal and Transperineal biopsies, Gleason Score, second opinion, MRI and MRI guided biopsies, PSA, simple prostatectomy (turp), ArteraAI Postate Test, active surveillance, Pi-RADS 4, PSA Velocity, urinary incontinence, Barrigel Spacer, Decipher and genetic testing, Promise Study, focal treatment, Prostate Screening Epi-Switch test.
Chat Log
Stuart
ming.zhou@mountsinai.org
John A
Ming Zhou, Mt Sinai or Johns Hopkins GU Pathology
AnCan – rick
Survey…. please complete! https://docs.google.com/forms/d/e/1FAIpQLSfw2B3rZTMWIPqTmzLYBl1CdN9qRJSpt0f72CoK6J00zllzWw/viewform
Bill Franklin
Well, I’m not looking for any new friends 😁 but I’m always happy to talk to anyone that wants information about AnCan or any other way I can help you out. bfranklin@ancan.org
Bill Franklin
Aim High
Sandy
above From Sandy Sund
AnCan – rick
Congrats to you, Paul N
Bob Weber
Thanks for all the information and guidance. As a result I have provided numerous recommendations on FB. I have taken the survey and will be donating this month. Both Mark and Rick have provided responses to my inquiries. I
AnCan – rick
AnCan Promise link https://www.prostatecancerpromise.org/?utm_campaign=ANCAN&utm_medium=link&utm_source=Webinar
AnCan – rick
@BobWeber – THANK YOU!
AnCan – rick
Here’s the UCSF Journal Club presentation on intraductal/cribriform, Stephen – please watch, and please pass along to Dr. Scholz with our complements. https://www.urotoday.com/video-lectures/a-journal-club-for-patients-with-prostate-cancer/video/mediaitem/4452-unfavorable-histology-classification-aims-to-reduce-unnecessary-treatment-journal-club-jesse-mckenney-cornelia-ding.html
Stephen (Vancouver)
Thankyou Rick, will check it out and try to pass it on to Dr. Scholz
Bill Franklin
Got to drop. Everyone have a good night!
Louis
I have to drop off as well. Thanks all. Have a good night.
Shirrell -Alabama
I am dropping as well. I hope everyone has a good evening and the LA area guys stay safe!
Joe M, Victoria BC
Gotta go –dinner time. Thanks to all.
It’s AnCan’s Annual Fundraiser time – just once a year is the only time we ask for donations. If you watch these videos and find them helpful, please step up ad donate – https://ancan.org/donate/
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Foundation Medicine, Janssen, Myriad Genetics, Novartis, Telix & Blue Earth Diagnostics.
WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.
All AnCan’s groups are free and drop-in … join us in person sometime!
Editor’s Pick: What technologies and practices are now considered state of art for prostate cancer treatment? (bj)
Topics Discussed
Post radiation treatment (40 grey/five sessions) update – five weeks out no side effects; Are rectal spacers needed?; Three commonly used rectal spacers are (1) Barrigel, (2) SpaceOAR, and (3) BioProtect; What is state of the art in prostate Cancer treatments?
Chat Log
AnCan – rick
Sorry I’m late Gents – was in our Pancreas Cancer Group. They switched their regular date this month.
Ancan would like your input on its future planning and academic research. Please take a few minutes to complete The 2024 AnCan Survey which is at thislink.
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Foundation Medicine, Janssen, Myriad Genetics, Novartis, Telix & Blue Earth Diagnostics.
WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.
All AnCan’s groups are free and drop-in … join us in person sometime!
Editor’s Pick: Focal therapy delays the time for more definitive treatment options. (bj)
Topics Discussed
Long-term treatment options for post radiation urinary issues; learn the importance of getting a second opinion on a prostate biopsy – active surveillance may be an option. Getting a Decipher test — testing to determine the liklihood of cancer spreading; Prostate Cancer Research Institute (PCRI) is a valuable information source; Additional tests to screen for prostate cancer, such as: EpiSwitch PSE and ExoDx Prostate Test; Considering focal treatment options with a cribriform pattern and intraductal indications — High-Dose (HDR) Brachytherapy, High Intensity Focal Ultrasound (HIFU) and Tulsa-PRO; Prostox DNA testing to determine risk for Genitourinary (GU) toxicity.
Chat Log
AnCan – rick
unauthorized!!!
Tim in Tampa
I completed the survey yesterday!
AnCan – rick
Tx Tim….
AnCan – rick
Ming Zhou https://profiles.mountsinai.org/ming-zhou
AnCan – rick
JH 2nd opinion https://pathology.jhu.edu/patient-care/second-opinions
Causley
Boykin is the star. He is the guru with this matter.
Ancan would like your input on its future planning and academic research. Please take a few minutes to complete The 2024 AnCan Survey which is at thislink.
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Foundation Medicine, Janssen, Myriad Genetics, Novartis, Telix & Blue Earth Diagnostics.
WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.
All AnCan’s groups are free and drop-in … join us in person sometime!
Editor’s Pick: Prognostic tools are a good starting point for discussing treatment options with your doctors. (bj)
Topics Discussed
Online resources to compare multiple prognostic tools (e.g., nomograms, PSMA, NCCN) to diagnose our disease; initial considerations for treatment decisions, such as: some urologists view younger men as better candidates for surgery — be careful of this bias when considering your treatment options; PROSTOX saliva swab for germline DNA testing and avoiding toxicity from radiation therapy; getting the right information so you can make an informed decision; post SBRT urination problems include: frequency, urgency, and discomfort (burning, stinging, tingling); clarification on SBRT (a treatment) and Meridian (a radiation machine); urgency and incontinence; active surveillance; RTIRE trial acceptance; AnCan survey emailed to you — let us know what you think; a little humor with emotional support llamas; Happy Veterans Day.
